Docosahexaenoic acid and arachidonic acid in infant development

Seminars in Neonatology

Volumn 6, Issue 5, 2001, Pages 437-449

  Carlson, Susan E ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; OMEGA 3 FATTY ACID;

CHILD DEVELOPMENT; DIETARY INTAKE; ESSENTIAL FATTY ACID DEFICIENCY; FAT INTAKE; HUMAN; INFANT; INFANT NUTRITION; MEDICAL RESEARCH; NONHUMAN; PRIMATE; REVIEW; THIRD TRIMESTER PREGNANCY;

EID: 0035740692     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1053/siny.2001.0093     Document Type: Article

References (119)

1. Distribution and fatty acid composition of phosphoglycerides in normal human brain
2. Lipids of ocular tissues. X. Lipid composition of subcellular fractions of bovine retina
3. Changing fatty acid content of growth cone lipids prior to synaptogenesis
4. Intrauterine fatty acid accretion rates in human brain: Implications for fatty acid requirements
5. Developmental profiles of polyunsaturated fatty acids in the brain of normal infants and patients with peroxisomal diseases: Severe deficiency of docosahexaenoic acid in Zellweger's and Pseudo-Zellweger's Syndromes
6. Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta
7. A comparison of the influence of breast-feeding and bottle-feeding on the fatty acid composition of erythrocytes
8. The effect of variations in dietary fatty acids on the fatty acid composition of erythrocyte phosphatidylcholine and phosphatidylethanolamine in human infants
9. Effect of dietary 18:ω-3 intake and postnatal age on the kinetics of elongation and desaturation of 18:ω-6 and 18:ω-3
10. The very low birth weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids
11. Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants
12. Intermediates in endogenous synthesis of C22:6 omega 3 and C20:4 omega 6 by term and pre-term infants
13. Docosahexaenoic acid status of preterm infants at birth and following feeding with human milk or formula
14. Effect of fish oil supplementation on the omega-3 fatty acid content of red blood cell membranes in pre-term infants
15. Increase in plasma phospholipid docosahexaenoic acid and eicosapentaenoic acids as a reflection of their intake and mode of administration
16. Infant cerebral cortex phospholipid fatty-acid composition and diet
17. Effect of diet on infant subcutaneous tissue triglyceride fatty acids
18. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants
19. Age- and dietary-related distributions of hepatic arachidonic and docosahexaenoic acid in early infancy
20. Essential fatty acid deficiency
21. Lipids and behavior: The evidence from animal models
22. Effects of dietary fatty acids on the fatty acid composition of brain ethanolamine phosphoglyceride: Reciprocal replacement of n-6 and n-3 polyunsaturated fatty acids
23. Biochemical and functional effects of prenatal and postnatal omega-3 fatty acid deficiency on retina and brain in rhesus monkeys
24. High fat diets varying in ratios of polyunsaturated to saturated fat and linolenic acid: A comparison of rat neural and red cell membrane phospholipids
25. Effect of dietary α-linolenate/linoleate balance on lipid compositions and learning ability in rats
26. The effects of dietary alphalinolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats
27. Polyunsaturated fatty acid status and neurodevelopment: A summary and critical analysis of the literature
28. The accumulation of arachidonate and docosahexaenoate in the developing rat brain
29. Comparative aspects of the brain growth spurt
30. Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys
31. The relationship of fatty acid composition to function in the retina and visual system
32. Supplementation with docosahexaenoic acid (22:63) fails to correct electroretinogram abnormalities produced by omega-3 fatty acid deficiency in rhesus monkeys
33. Effects of n-3 fatty acid deficiency on retinal physiology and visual function
34. Visual attention in infant monkeys: Effects of dietary fatty acids and age
35. Relationships between visual acuity and visual attention measures in rhesus monkey infants
36. Visual acuity development in healthy pre-term infants. Effect of marine oil supplementation
37. The effect of long chain n-3 fatty acid supplementation on visual acuity and growth of pre-term infants with and without bronchopulmonary dysplasia
38. A randomized trial of visual attention of pre-term infants fed docosahexaenoic acid until 9 months
39. A randomized trial of visual attention of pre-term infants fed docosahexaenoic acid until 2 months
40. Early visual acuity does not correlate with later evidence of visual processing in pre-term infants although each is improved by the addition of docosahexaenoic acid to infant formula
41. Assessment of long-chain polyunsaturated fatty acid nutritional supplementation on infant neurobehavioral development and visual acuity
42. Growth and development in pre-term infants fed long-chain polyunsaturated fatty acids: A prospective, randomized controlled trial
43. Individual differences in early visual attention: Fixation time and information processing
44. Individual differences in infant visual attention: Are short lookers faster processors or feature processors?
45. Components of visual orienting in early infancy: Contingency learning, anticipatory looking and disengaging
46. Effect of n-3 fatty acid deficiency in nonhuman primates
47. Home cage behavior of rhesus monkeys with long-term deficiency of omega-3 fatty acids
48. Postnatal deficiency of omega-3 fatty acids in monkeys: Fluid intake and urine concentration
49. Recent advances in infant cognition: Implications for LC-PUFA supplementation studies
50. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 month of age
51. Influence of long-chain polyunsaturated fatty acids on infant cognitive function
52. Long-chain polyunsaturated fatty acid supplementation of pre-term infants
53. Pathway of alpha-linolenic acid through the mitochondrial outer membrane in the rat liver and influence on the rate of oxidation. Comparison with linoleic and oleic acids
54. Stimulation of the activities of hepatic fatty acid oxidation enzymes by dietary fat rich in alpha-linolenic acid in rats
55. Peroxisomal beta-oxidation and catalase activity during development and aging in mouse liver
56. A randomized clinical trial of docosahexaenoic acid supplementation during the third trimester of pregnancy and pregnancy outcome
57. Maternal and neonatal essential fatty acid status in phospholipids: An international comparative study
58. Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status
59. Blood lipid concentrations of docosahexaenoic acid and arachidonic acid at birth determine their relative postnatal changes in term infants fed breast milk or formula
60. Will dietary omega-3 fatty acids change the composition of human milk?
61. Increased docosahexaenoic acid levels in human newborn infants by administration of sardines and fish oil during pregnancy
62. Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants
63. Docosahexaenoic acid is transferred through maternal diet to milk and to tissues of natural milk-fed piglets
64. Effect of vegetable and marine oils in pre-term infant formulas on blood arachfdonic and docosahexaenoic acids
65. Changes in the maternal essential fatty acid profile during early pregnancy and the relation of the profile to diet
66. Docosahexaenoate (DHA) and eicosapentaenoate (EPA) supplementation of pre-term (PT) infants: Effects on phospholipid DHA and visual acuity
67. Effect of dietary omega-3 fatty acids on retinal function of very-low-birth-weight neonates
68. Retinal development in very low birth weight infants fed diets differing in omega-3 fatty acids
69. Are long-chain polyunsaturated fatty acids essential nutrients in infancy?
70. Docosahexaenoic acid in developing brain and retina of piglets fed high or low alpha-linolenate formula with and without fish oil
71. Arachidonic acid status of human infants: Influences of gestational age at birth and diets with very long chain n-3 and n-6 fatty acids
72. Arachidonic acid status correlates with first year growth in pre-term infants
73. First year growth of pre-term infants fed standard compared to marine oil n-3 supplemented formula
74. Effect of DHA-containing formula on growth of pre-term infants to 59 weeks postmenstrual age
75. Polyunsaturated fatty acids and infant growth
76. Visual acuity, erythrocyte fatty acid composition, and growth in term infants fed formulas with long chain polyunsaturated fatty acids for one year. Ross Pediatric Lipid Study
77. Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infantformula milk: A randomized trial
78. Growth and development in term infants fed long-chain polyunsaturated fatty acids: A double-masked, randomized, parallel prospective, multivariate study
79. Growth and development of term infants fed formulas with docosahexaenoic acid (DHA) from algal oil or fish oil and arachidonic acid from fungal oil
80. Docosahexaenoic acid plus arachidonic acid enhance pre-term infant growth
81. Evaluation of a long-chain polyunsaturated fatty acid supplemented formula on growth, tolerance, and plasma lipids in pre-term infants up to 48 weeks postconceptional age
82. A multicenter long-term safety and efficacy trial of pre-term formula supplemented with long-chain polyunsaturated fatty acids
83. Essential fatty acids in visual and brain development
84. Randomized trials with polyunsaturated fatty acid interventions in preterm and term infants: Functional and clinical outcomes
85. The role of docosahexaenoic acid in retinal function
86. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina
87. Considerations of statistical power in studies of visual development and DHA status. Invited editorial
88. Long chain polyunsaturated fatty acid supplementation in pre-term infants
89. Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy pre-term infants
90. Dietary essential fatty acids, long-chain polyunsaturated fatty acids, and visual resolution acuity in healthy fullterm infants: A systematic review
91. Long chain polyunsaturated fatty acid supplementation in infants born at term
92. Effects of maternal docosahexaenoic acid supplementation on visual function and growth of breast-fed infants
93. Effects of maternal docosahexaenoic acid (DHA) supplementation on visual function and neurodevelopment of breast-fed infants
94. Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotonergic neurotransmission in rats
95. α-linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotonergic neurotransmission in the rat frontal cortex
96. PUFAs and cerebral function: Focus on monoaminergic neurotransmission
97. Omega-3 fatty acid deficiency and behavior: A critical review and directions for future research
98. Diverse, region-specific effects of addition of arachidonic and docosahexaenoic acids to formula with low or adequate linoleic and alpha-linolenic acids on piglet brain monoaminergic neurotransmitters
99. Dietary fatty acid in composition in pregnancy alters neurite membrane fatty acids and dopamine in newborn rat brain
100. Docosahexaenoic acid reduces GABA response in substantia nigra neuron of rat
101. Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in strokeprone spontaneously hypertensive rats
102. 18 neuroblastoma cells
103. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid
104. Anadamide modulates sleep and memory in rats
105. Anandamide: A candidate neurotransmitter heads for the big leagues
106. Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets
107. Effect of dietary n-3 fatty acids upon the phospholipid molecular species of the monkey retina
108. Mechanisms of action of docosahexaenoic acid in the nervous system
109. Docosahexaenoic acid protects retinal photoreceptors from apoptosis induced by oxidative stress
110. Docosahexaenoic acid (DHA) mediates anti-apoptotic effects through phosphatidylinositol 3-kinase pathway: A novel observation in neural apoptosis
111. Ligand selectivity of the peroxisome proliferator-activator receptor alpha
112. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain
113. Effect of low brain docosahexaenoic acid on gene expression in rat frontal contex
114. Effects of docosahexaenoic acid on retinal development. Cellular and molecular aspects
115. Long chain polyunsaturated fatty acids (LCPUFA) and perinatal development
116. Human milk and formula fatty acids
117. The fatty acid composition of human milk in Europe and Africa